marcus evans europe conferences

5th edition IDMP as a Long Term Information Management Project

Working towards effective information management and data as an asset vision with tangible business benefits while breaking silos between divisions

27-29 November 2017
Berlin, Germany


Why You Should Attend

5th edition IDMP as a Long Term Information Management Project

This marcus evans conference will focus on gathering corporate professionals from Regulatory Operations, Regulatory Affairs, Master Data Management, Regulatory Information Systems and other key stakeholder departments progressing on IDMP projects in the uncertainty context with already some lessons learnt and practices to share for those who are less advanced in the journey.

Join this practitioner IDMP knowledge exchange platform to discuss latest regulatory developments from EMA, FDA developments on GINAS and hear a number of case studies on IDMP projects, technology selection, preparations for the first iteration, practical experiences on unstructured information and other key areas compliance requirements preparations.


Key Topics

  • Turn IDMP into long term information management project
  • Realise IDMP benefits outside of compliance
  • Establish good data quality production and maintenance
  • Discuss good practices around structuring unstructured data
  • Manage effective compliance work and IDMP strategy in the uncertainty context
  • Previous Attendees Include

    Abbott Laboratories GmbH ∙ Allerghan ∙ Allergopharma GmbH & Co. KG ∙ ArisGlobal GmbH ∙ Aspen Pharma Trading Ltd ∙ Astellas ∙ Bayer Pharma AG ∙ BioMarin Pharmaceutical Inc ∙ Boehringer Ingelheim Pharma GmbH & Co ∙ Celgene Europe Limited ∙ Chiesi Farmaceutici SpA ∙ e-DRA Harmsen ∙ Ernst & Young AG ∙ F.Hoffmann-La Roche Ltd ∙ Ferring International Center SA ∙ Fresenius Kabi Deutschland GmbH ∙ Fresenius Netcare GmbH ∙ Gartner Inc ∙ Genpact Pharmalink ∙ Grunenthal GmbH ∙ Guerbet ∙ HAL Allergy ∙ HighPoint Solutions LLC ∙ i4i Inc ∙ Informatica Corporation ∙ Infotehna ∙ IT-Consulting Life Science ∙ Janssen Pharmaceutical ∙ Johnson & Johnson ∙ Kinapse ∙ LEO Pharma A/S ∙ Marr Consultancy Ltd ∙ Merck Sharp & Dohme ∙ Mesa Arch Consulting ∙ mibe GmbH Arzneimittel ∙ NNIT ∙ Norgine ∙ Novartis Pharma AG ∙ Oracle ∙ Orion Pharma ∙ PAREXEL ∙ Pfizer Incorporated ∙ Pierre Fabre Laboratories ∙ Reckitt Brnckiser Pharmaceuticals ∙ Roche ∙ Sanofi Pasteur MSD – SNC ∙ SAS Institute A/S ∙Shire International GmbH ∙ Stada Arzneimittel AG ∙ Stallergenes SA ∙ Takeda Pharma A/S ∙ Teelia EU ∙ Teva Pharmaceuticals ∙ UCB Biopharma SPRL ∙ Xendo Deutschland GbmH


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.







    Voice of Our Customers
    • “Very fruitful conference, excellent presenters. Thank you.” IDMP Project Lead, Novartis Pharma AG
    • “Great job!” Research Director, Gartner
    • “Very targeted and productive event. Topic is timely and current.” VP, Life Sciences R&D Practice, HighPoint Solutions
    Latest Conference News & Resources



    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Melini Hadjitheori


    PO Box 24797
    CY-1304 Nicosia


    Telephone:
    +357 22 849 308
    Fax: +357 22 849 394
    Email: MeliniH@marcusevanscy.com